iOnctura
iOnctura operates as a clinical-stage biotechnology company that specializes in developing a treatment for cancer.
Total raised
€113M
€112,914,879
Funding rounds
4
Investors
10
distinct backers
Active since
2020-01
latest 2024-06
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood59
base rate 48% for Series B
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood28
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €100M+ raised
- ▲ 9y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-06-24 | Series B | €80M | 3B Future Health Fund,EIC Fund,Inkef Capital,M Ventures,Schroders Capital,Syncona Limited+1 more | View deal → |
| 2022-12-21 | Other | €18M | EIC Accelerator | View deal → |
| 2022-09-22 | Seed | €415k | Fongit Innovation Fund (FIF) | View deal → |
| 2020-01-23 | Series A | €15M | INKEF Capital,VI Partners | View deal → |
Investors
10Related news
- iOnctura Receives €17.5M Funding from the EIC Acceleratorfinsmes.com · 2022-12
- FIF funding supports three women led deeptech startupsstartupticker.ch · 2022-09
- spotfolio.com
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy